NovoSeven Articles
Stock Commentary - New York
7 June 2004
Baxter gets FDA warning on ADVATE promotion
7 June 2004
FDA OKs Serono's Gonal-f RFF Pen
31 May 2004
Wockhardt to export insulin to SE Asia
24 May 2004
PPL reports flat income for full-year 2003
10 May 2004
Tercica gets rights to rhIGF-I from Fujisawa
10 May 2004
NPS and Nycomed sign Preos deal
26 April 2004
ZymoGenetics' thrombin in Ph II
26 April 2004
FDA clears Aventis' insulin Apidra
26 April 2004
Halozyme in manufacturing deal with Avid Bioservices
19 April 2004
Unigene in calcitonin deals with Novartis
19 April 2004
Positive Phase III results for NPS' Preos
5 April 2004
Serono's Serostim helps lean body mass
5 April 2004
Dragon to merge into Oriental Wave
5 April 2004
Xoma sees net loss jump as revenues fall
22 March 2004
Serologicals expands distribution deal with Novo Nordisk
15 March 2004
Serono's Gonal-f pre-filled pen gets OK from EC
8 March 2004
Ph IIa results for Dyax' DX-890
1 March 2004
UK NHS to offer free IVF treatment
1 March 2004
NovoSeven cleared in EU for two new uses
1 March 2004
Novartis' Slovenian subsidiary Lek boosts biopharma activity
23 February 2004
Affitech gets FUGE grant for new cancer drug
23 February 2004
Novo Nordisk profits up 19% in 2003
16 February 2004
Nuvelo licenses novel anticoagulant
16 February 2004
GTC Bio restructures to support programs
9 February 2004
S-P launches Rebetol oral solution in USA
26 January 2004
Corixa and GSK to start trial for TB vaccine
26 January 2004
BioSante gets DynPort anthrax subcontract
19 January 2004
Avid Bio expands capacity
5 January 2004
Xoma/Millennium's MLN2222 enters Ph I
5 January 2004
Roche signs Japanese deal with Chugai
22 December 2003
HIV vaccine begins small-scale clinical trial in Belgium
22 December 2003
Generex initiates feasibility study on rHGH
15 December 2003
Positive long-term findings for Aryplase
17 November 2003
Serono beats expectations with 3rd-qtr 2003 net income up 48%
3 November 2003
Improving the treatment of anemia in cancer, discussed at ECCO
20 October 2003
BioProtein to milk platform technology following extension
20 October 2003
Positive news for Serono's Luveris
13 October 2003
Meridian Bioscience gains NIH award for Parvovirus vaccine
13 October 2003
ZymoGenetics deal with Abbott on human Thrombin
13 October 2003
PPL Therapeutics to sell business after key investors lose faith
22 September 2003
First approval of Berna Biotech's hep B vaccine
15 September 2003
Ipsen and Octagen start Ph I for OBI-1
15 September 2003
Dutch biotech Crucell hires US investor relations firm
8 September 2003
FDA approves Baxter hemophilia drug
4 August 2003
Serono raises 2003 forecast; 2nd-qtr figs
4 August 2003
Meridian to make/ distribute Corixa Chagas' proteins
28 July 2003
Tokyo pharma stocks - week to July 14
21 July 2003
XOMA closes license deal with Baxter
14 July 2003
India: Phase III trials for biotech imports
14 July 2003
Novo Nordisk's Norditropin cleared by EC
7 July 2003
Vaxgen opens new facility in California
30 June 2003
Italy seeks US aid over Pompe disease
30 June 2003
Bio-Tech General changes name to Savient
23 June 2003
Tokyo pharma stocks - week to June 16
23 June 2003
Genzyme's Myozyme begins Pompe study
9 June 2003
EPO boosts Dragon Pharma revenues
9 June 2003
Modest growth for Ipsen in 2002
2 June 2003
1st-qtr results for France's Transgene
12 May 2003
China fast-tracks SARS Rx approvals, imports
12 May 2003
Serono
5 May 2003
Serono to invest $5.4M in SPain
21 April 2003
Medtronik/Wyeth's rhBMP-2 device cleared in Canada
14 April 2003
TKT gets two US gene therapy patents
31 March 2003
New use for Norditropin backed in EU
31 March 2003
Beaufour gets EU Ok for Nutropin AQ
24 March 2003
Vical to trial anthrax vaccine by year end
17 March 2003
4th-qtr charges hit Genzyme General
17 March 2003
Baxter, Arriva trial rec alpha-1 antitrypsin
10 March 2003
Baxter gains major Canadian blood product contract
10 March 2003
Virax shares slump as HIV trial disappoints
24 February 2003
Study questions long-term IFN use in MS
24 February 2003
J&J confirms $2.4 billion offer for Scios
17 February 2003
2002's crop of new product launches backs up R&D fears
10 February 2003
IVAX to develop new HIV approach
10 February 2003
Wockhardt to launch Indian insulin product
10 February 2003
Wyeth licenses VSV patents to GTx
3 February 2003
Amgen's mucositis drug clears Phase III trial
3 February 2003
GeoVax HIV vaccine heads for trials
3 February 2003
LSBC's plant-based Fabry drug gets orphan status in USA
27 January 2003
BioPartners, Rentschler to take on MS market
20 January 2003
Blow for ICOS as sepsis drug fails in Phase III
6 January 2003
DSM Biologics signs up with Crucell
6 January 2003
- Is failure to adopt business process management putting the pharma industry at risk?
- Ignyta acquires Actagene Oncology and entry into cancer personalized medicine
- New Zealand declines Alexion's funding application for Solaris
- HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst
- Elan makes "transformational" acquisitions and a divestment
